Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab vs placebo in Chinese postmenopausal women with osteoporosis
CTR20192682Phase 3Completed
- Sponsor
- Amgen
- Start
- Feb 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of romosozumab in osteoporosis, sponsored by Amgen. Started Feb 2020; status: completed.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20192682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192682.